Liu S et al.miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.Pigment Cell Melanoma Res 28:431-41 (2015).
PubMed: 25903073
Liu S et al.miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.Am J Pathol 181:1823-35 (2012).
WB
;
Human
.
PubMed: 22982443
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"